Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-03-08

Clinical Trial Update: Efficacy of Combination of Hdroxyurea and Thalidomide Over Either Hydroxyurea or Thalidomide Alone in the Treatment of Transfusion Dependent Thalassemia in Children: A Quasi-Randomised Clinical Trial [Phase 4]

View source ↗

Summary

A Phase 4 quasi-randomised trial evaluates the efficacy of combining hydroxyurea and thalidomide versus each agent alone in children with transfusion-dependent …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HYDROXYUREA (Hydroxyurea)
  • Thalidomide (thalidomide)

Snippet

Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Conditions: Transfusion-dependent Thalassemia | Phase 4 | Status: UNKNOWN